WHY SWITCH?
Unlocking Genetic Potential
SWITCH Biotech is partnered with Way2Grow Biopharma, a Health Canada licensed facility with a focus on a biomedical approach to wellbeing. Switchbio’s extensive research and IP approach is focused on the development of several new plant-based cultivation techniques, hybrid cultivar development, genetic sequencing and establishing tissue culture growth plans.
OUR MISSION
Developing Innovative Biotechnology to Advance Genetic Diversity.
WHY SWITCH?
Developing a Gene Editing Platform
MAD7 is a royalty and license free gene editing platform that can be programmed for use in plant and fungi cells
Developing a Unique Genetic Library
Development of an extensive collection of cannabis and mushroom varieties that can be introduced into the trait development and breeding pipeline
Plant Transformation Capabilities
Genetic transformation of cannabis has proven to be a major challenge in the industry. Our expertise in tissue culture will address this issue to optimize genetic transformation processes
Customized Unique Genetics
Develop custom cannabis and mushroom varieties based on end-user requirements through a number of techniques including gene editing and mutagenesis
Exploring New Cannabis Breeding Tools a Title
Developing double haploid breeding technology to develop high yielding hybrid cannabis varieties
Plant Genotyping and Phenotyping
Development of high throughput DNA sequencing and phenotyping to facilitate molecular breeding programs for cannabis and mushroom
Unlocking Genetic Potential
​
OUR TEAM
CEO & Founder
Founder of SWITCH Biotech Corp. and Founder of Way2Grow Biopharma Corp. CEO & QAP. - Specialized in Business Development of Medical Cannabis and Psilocybin Production Facilities. Business Development Manager with over 20 years experience in cannabis, power, oil & gas, and agriculture industries. Experienced Quality Assurance & Quality Control, and Facility Optimization.
​
CSO & Founder
Founder of SWITCH Biotech Corp. PHD Candidate in Plant Developmental Biology, BSc. Plant Botany. Specialized in Plant Genetics, Plant Development, and Biotechnology. Dr. Skori has developed new biotechnology to address the demand for improving protein content in plant tissues using advanced genomics and molecular plant breeding techniques including gene-editing.
CRO & Founder
Founder of SWITCH Biotech Corp. & Way2Grow Biopharma. PhD Simon Fraser University, Tenured Professor specialized in advanced statistics, advanced research methods, multivariate data analysis & standardization. Found of Way2Grow Biopharma Corp. Experienced in geographic information systems, criminal intelligence and criminal profiling, research publications & grant writing.